Deutsche Börse and NYSE Euronext Tuesday said they had submitted enhanced remedy proposals for their planned merger to the European Union's antitrust oversight body aimed at winning key approval for the deal.
A main focus of the remedies to the European Commission would be to ease market-dominance concerns in the exchanges' combined derivatives business.